Picture of ISR Immune System Regulation Holding AB (publ) logo

ISR ISR Immune System Regulation Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: ISR HBV Investigates Program For Coronavirus

Feb 25 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * SAID ON MONDAY UNIT ISR HBV BROADENS ITS DEVELOPMENT
PORTFOLIO
BY INCLUDING CORONAVIRUS AS POSSIBLE CANDIDATE FOR TREATMENT
WITH CO'S IMMUNOLID ISR50

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr36M61p
    
 Further company coverage:  ISR.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))

Recent news on ISR Immune System Regulation Holding AB (publ)

See all news